Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 6/20 | 0.67 |
| ▸ | MAOA | P21397 | 5/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.67 |
| ▸ | SDHA | P31040 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | CALML3 | P27482 | 1/20 | 0.67 |
| ▸ | F10 | P00742 | 4/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2591003 | 1.00 | MAOB (0.67) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL2406825 | 1.00 | MAOB (0.67) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL6854026 | 0.89 | MAOA (0.53) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL28998570 | 0.85 | MAOB (0.68) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL27801851 | 0.85 | MAOB (0.68) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL2046431 | 0.84 | MAOB (0.46) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL7030086 | 0.84 | MAOB (0.61) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL3181066 | 0.84 | MAOA (0.60) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL6097931 | 0.84 | MAOB (0.48) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL3519815 | 0.84 | MAOB (0.48) | MAOBMAOAPTGS1SDHALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030216572-A1 | PROCESS TO PRODUCE OXAZOLIDINONES | PHARMACIA & UPJOHN COMPANY | 2003-11-20 | — | — | US | claimed |
| US-20030130509-A1 | PROCESS TO PRODUCE 3-CARBON AMINO ALCOHOL SALTS | PHARMACIA & UPJOHN COMPANY | 2003-07-10 | — | — | US | claimed |
| US-20020032348-A1 | Process to produce oxazolidinones | PEARLMAN BRUCE ALLEN (US) | 2002-03-14 | — | — | US | claimed |
| CN-115236236-A | Linezolid and separation and analysis method of enantiomers in preparation thereof | 上海市食品药品检验研究院 | 2022-10-25 | — | — | CN | disclosed |
| CN-113995726-A | Linezolid II crystal form tablet and preparation method thereof | 深圳万乐药业有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-113045509-B | Industrial production method of linezolid | 上海翰森生物医药科技有限公司 | 2021-10-22 | — | — | CN | disclosed |
| CN-113045509-A | Industrial production method of linezolid | 上海翰森生物医药科技有限公司 | 2021-06-29 | — | — | CN | disclosed |
| US-RE47606-E1 | Process for the preparation of linezolid | OPTIMUS DRUGS PRIVATE LIMITED (IN) | 2019-09-17 | — | — | US | disclosed |
| EP-2899185-B1 | Processes for preparing linezolid | UNIV INDIANA RES & TECH CORP (US) | 2018-01-31 | — | — | EP | disclosed |
| EP-3250568-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF LINEZOLID | Optimus Drugs Pvt Ltd (IN) | 2017-12-06 | — | — | EP | disclosed |
| WO-2017182853-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF LINEZOLID | OPTIMUS DRUGS PVT LTD (IN) | 2017-10-26 | — | — | WO | disclosed |
| WO-2002085849-A2 | PROCESS TO PREPARE OXAZOLIDINONES | PHARMACIA & UPJOHN COMPANY (US) | 2002-10-31 | — | — | WO | disclosed |
| US-20020095054-A1 | Process to produce oxazolidinones | PHARMACIA & UPJOHN COMPANY | 2002-07-18 | — | — | US | disclosed |
| US-6410788-B1 | BACTERICIDES; REACTING IMINE, CARBAMATE, ESTER, AMIDE AND EPOXIDE DERIVATIVES | PHARMACIA & UPJOHN COMPANY | 2002-06-25 | — | — | US | disclosed |
| US-6362334-B1 | OXAZOLIDINONE PHTHALAMIDE | PHARMACIA & UPJOHN COMPANY | 2002-03-26 | — | — | US | disclosed |
| US-20020032348-A1 | Process to produce oxazolidinones | PEARLMAN BRUCE ALLEN (US) | 2002-03-14 | — | — | US | disclosed |
| US-6239152-B1 | Oxazolidinone combinatorial libraries, compositions and methods of preparation | PHARMACIA & UPJOHN COMPANY | 2001-05-29 | — | — | US | disclosed |
| EP-1049682-A1 | OXAZOLIDINONE COMBINATORIAL LIBRARIES, COMPOSITIONS AND METHODS OF PREPARATION | Versicor, Inc. (US) | 2000-11-08 | — | — | EP | disclosed |
| US-6107519-A | Process to produce oxazolidinones | PHARMACIA & UPJOHN COMPANY (US) | 2000-08-22 | — | — | US | disclosed |
| WO-1999037630-A1 | OXAZOLIDINONE COMBINATORIAL LIBRARIES, COMPOSITIONS AND METHODS OF PREPARATION | VERSICOR, INC. (US) | 1999-07-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130509-A1 | PROCESS TO PRODUCE 3-CARBON AMINO ALCOHOL SALTS | ADH1A, ADH5, ADH1C | MAOB 652/4885MAOA 413/4885PTGS1 3186/4885 |
| US-20020095054-A1 | Process to produce oxazolidinones | ADH1A, ADH5, ADH1C | MAOB 189/4885MAOA 156/4885PTGS1 2552/4885 |
| US-20030216572-A1 | PROCESS TO PRODUCE OXAZOLIDINONES | ADH1A, ADH5, ADH1C | MAOB 189/4885MAOA 156/4885PTGS1 2552/4885 |
| US-20020032348-A1 | Process to produce oxazolidinones | ADH1A, ADH5, ADH1C | MAOB 189/4885MAOA 156/4885PTGS1 2552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.